The proposed training program will provide predoctoral and postdoctoral trainees with a solid academic background in immunology with emphasis on multi disciplinary approaches to study common mechanisms of inflammation. Training will include relevant course work, regularly scheduled seminars and journal clubs, and rigorous laboratory training with the goal of preparing our trainees for careers in research related to the goals of this program. Boston University has an outstanding group of faculty with long standing interests in inflammatory disorders who are members of the Boston University Training Program in Inflammatory Disorders (BU-TPID). In addition, recent recruitment efforts have resulted in the formation of a critical mass of established investigators and accordingly this application proposes to establish an integrated training program for predoctoral students and postdoctoral fellows in inflammatory disorders. In addition to their common research interests, many of these faculties already have substantial evidence for collaborative interactions including NIH support. Faculty research interests encompass three broad research areas including 1) Pathogen induced inflammation;2) Chronic non-communicable inflammatory disorders;and 3) Therapeutics and preventative strategies. The BU-TPID Training Faculty all are current NIH grant recipients with funding from 10 NIH Institutes, and who, as a group have had substantial training history. As a whole this group enjoys national and international recognition in their respective fields. As part of this training grant the Core training faculty will also be involved in mentoring additional junior faculty members. The BU-TPID faculty represent a broad range of departmental affiliations, including the Departments of Medicine, Microbiology, Pathology, Physiology and Biophysics at the Boston University School of Medicine, the Department of Environmental Health at the Boston University School of Public Health, the Department of Oral Biology and Peridontology at the School of Dental Medicine and the Department of Biomedical Engineering at the Boston University College of Engineering. The major goals of the program will be to 1) Recruit and enroll students of the highest quality, including underrepresented minorities;2) Provide these trainees with a multidisciplinary background in inflammatory disorders coupled with intensive laboratory training in a particular research topic;3) To teach the trainees critical thinking skills and how to ask relevant and feasible research questions;4) To instill these trainees with a sense of ethical behavior;5) To help develop effective written and oral communication skills among the trainees;6) To facilitate collaborative interactions among both trainees and faculty of the training program and 7) To mentor Junior faculty members in pre and post doctoral training.

Public Health Relevance

The rationale for establishing the BU-TPID was based on the common research interests of a number of investigators at Boston University, the recognition of the need to establish an integrated program in inflammatory disorders, and to train students and fellows in common mechanisms of inflammation with particular emphasis on clinical and translational science. A hallmark of the BU-TPID is its interschool, interdepartmental and interdisciplinary nature.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI089673-03
Application #
8510562
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
2011-09-15
Project End
2016-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
3
Fiscal Year
2013
Total Cost
$297,077
Indirect Cost
$17,265
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Agosto, Luis M; Herring, Melissa B; Mothes, Walther et al. (2018) HIV-1-Infected CD4+ T Cells Facilitate Latent Infection of Resting CD4+ T Cells through Cell-Cell Contact. Cell Rep 24:2088-2100
Wasserman, Gregory A; Szymaniak, Aleksander D; Hinds, Anne C et al. (2017) Expression of Piwi protein MIWI2 defines a distinct population of multiciliated cells. J Clin Invest 127:3866-3876
Nicholas, Dequina A; Andrieu, Guillaume; Strissel, Katherine J et al. (2017) BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer. Cell Mol Life Sci 74:231-243
Nicholas, Dequina; Proctor, Elizabeth A; Raval, Forum M et al. (2017) Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis. PLoS One 12:e0170975
Blaha, Laura; Zhang, Chentian; Cabodi, Mario et al. (2017) A microfluidic platform for modeling metastatic cancer cell matrix invasion. Biofabrication 9:045001
Nicholas, Dequina A; Nikolajczyk, Barbara S (2016) B cells shed light on diminished vaccine responses in obesity. Obesity (Silver Spring) 24:551
Strissel, Katherine J; Nicholas, Dequina A; Castagne-Charlotin, Myriam et al. (2016) Barriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research. Clin Med Insights Womens Health 9:57-61
Payne, Julia G; Takahashi, Ayuko; Higgins, Michelle I et al. (2016) Multilineage transduction of resident lung cells in vivo by AAV2/8 for ?1-antitrypsin gene therapy. Mol Ther Methods Clin Dev 3:16042
Lee, E L; Bendre, H H; Kalmykov, A et al. (2015) Surface modification of uniaxial cyclic strain cell culture platform with temperature-responsive polymer for cell sheet detachment. J Mater Chem B 3:7899-7902
Parello, Caitlin S L; Mayer, Chad L; Lee, Benjamin C et al. (2015) Shiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury. Toxins (Basel) 7:170-86

Showing the most recent 10 out of 20 publications